AKBA - Akebia Therapeutics Inc. (AKBA) Q1 2024 Earnings Call Transcript
2024-05-09 10:54:12 ET
Akebia Therapeutics, Inc. (AKBA)
Q1 2024 Earnings Conference Call
May 09, 2024, 8:00 AM ET
Company Participants
Mercedes Carrasco - Senior Director, Corporate Communications and IR
John Butler - President and Chief Executive Officer
Nicholas Grund - Chief Commercial Officer
Conference Call Participants
Ed Arce - H.C. Wainwright
Julian Harrison - BTIG
Presentation
Operator
Hello, and welcome to the Akebia's First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
It is now my pleasure to introduce Senior Director, Investor Relations Mercedes Carrasco.
Mercedes Carrasco
Thank you and welcome to Akebia's first quarter 2024 financial results and business update conference call. Please note that a press release was issued earlier today, Thursday, May 9th, detailing our first quarter financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will also be available on our website after we conclude.
Joining me for today's call, we have John Butler, Chief Executive Officer and Principal Financial Officer; and Nick Grund, Chief Commercial Officer....
Akebia Therapeutics, Inc. (AKBA) Q1 2024 Earnings Call Transcript